PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.65%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-23.18%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
4.46%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
5.15%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
-8.08%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.00%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
-5.86%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
185.62%
D&A growth above 1.5x CRWV's 26.15%. Michael Burry would check for excessive investment.
29.53%
Similar EBITDA growth to CRWV's 33.05%. Walter Schloss would investigate industry trends.
78.43%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
5.63%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
6.33%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
5.19%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
5.51%
Pre-tax income growth 50-75% of CRWV's 9.63%. Martin Whitman would scrutinize operations.
6.20%
Pre-tax margin growth below 50% of CRWV's 26.86%. Michael Burry would check for structural issues.
2.33%
Tax expense growth 50-75% of CRWV's 3.78%. Bruce Berkowitz would examine efficiency.
-8.43%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-7.82%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-4.55%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-9.09%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
2.55%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.56%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.